Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?

https://doi.org/10.4081/monaldi.2018.971

Authors

Abstract

Some observational studies raised questions about the need for β-blockers in all patients after a first heart attack. Surprisingly, in some clinical settings, a limited mortality reduction was found in those who received β-blockade.Some studies suggest that patients without heart failure may not need post-MI β-blockers. The lack of data from randomized controlled clinical trials has led to clinical uncertainty and conflicting recommendations. Therefore, there are multiple information to revaluate the value of β-blocker therapy after a heart attack in absence of heart failure or left ventricular dysfunction and the time for new trials of an old group of drugs has arrived.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2018-06-07
Info
Issue
Section
Cardiology - Original Articles
Keywords:
Beta Blockers, Secondary prevention, Myocardial infarction
Statistics
  • Abstract views: 2822

  • PDF: 376
How to Cite
Pedretti, Roberto F.E. 2018. “Beta-Blockers After Myocardial Infarction: Are They Useful to All Patients? And How Long Should Be the Beta-Blocker Therapy?”. Monaldi Archives for Chest Disease 88 (2). https://doi.org/10.4081/monaldi.2018.971.

Most read articles by the same author(s)